ArticleFrontiers in oncology2026

Respiratory adverse events associated with PD-1/PD-L1 inhibitors: an analysis based on the FDA adverse event reporting system.

Zhenyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.